Programmed death-ligand 1 (PD-L1) and cytotoxic T lymphocyte marker CD8 have been implicated in tumor immune evasion and prognosis in various malignancies, while Maspin, a tumor suppressor, has shown a negative prognostic impact in sarcomas. The gene discussed is CD8A; the disease is sarcoma.